Senti Biosciences (NasdaqCM:SNTI) FY Conference March 02, 2026 03:10 PM ET Company ParticipantsEllen Horste - Equity Research AssociateKanya Rajangam - President, Head of Research and Development, and Chief Medical OfficerTimothy Lu - Co-Founder and CEOConference Call ParticipantsPhil Nadeau - Managing Director and Research AnalystNone - AnalystEllen HorsteAfternoon, welcome back to TD Cowen's 46th Annual Healthcare Conference. I'm Ellen Horste, TD Cowen Biotech Associate. On behalf of Phil Nadeau's team, I ...